The latest news from the British Thoracic Oncology Group (BTOG):
BTOG wishes to inform members of a new NICE approval that has been published today. NICE has now reappraised dabrafenib-trametinib for BRAF V600E mutant advanced NSCLC and given a positive recommendation for the submitted indication: 1st line BRAF V600E advanced … Read More
Congratulations to all of the poster winners at BTOG 2023. The full list of the four 1st prize winners and the ten runners up can be downloaded here.
NICE has published the Tobacco: Treating Dependence quality standard (QS207). BTOG endorses this hugely helpful quality standard which covers support and treatment to stop smoking and stop using smokeless tobacco, and harm-reduction approaches for people who are not ready to … Read More
BTOG is delighted to welcome Julia McAdam to the steering committee. Julia, who is Lead Lung Cancer Clinical Nurse Specialist at Shrewsbury and Telford Hospital NHS Trust, joins as a nurse representative, replacing Karen Clayton who has stepped down from … Read More
Dr Liz Toy and Dr Paul Beckett – GIRFT’s clinical leads for lung cancer – along with Professor Tim Briggs, Chair of the GIRFT programme and national director of clinical improvement for NHS England, will be hosting a lunchtime webinar … Read More
BTOG is delighted to welcome Paula Shepherd to the steering committee. Paula is currently a lung cancer clinical nurse specialist at Liverpool University Hospital Foundation Trust. She qualified as an RGN in 2001 and her main experience has been gained … Read More
The National Lung Cancer Audit (NLCA) has published its latest annual report. Utilising data provided by Public Health England (PHE), Rapid Cancer Registration Dataset (RCRD) for England, the Welsh Cancer Network and lung cancer teams in Guernsey, the report provides … Read More
Trainee Journal Clubs Wednesday 27th April 2022, 17:30-18:30 BSTThis session focuses on SCLC. We will be discussing the following paper: Durvalumab, with or without tremelimumab, plus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer: 3-year overall survival update from … Read More
The winning posters from BTOG 2022 are available to view in this presentation.
All of the successful abstracts submitted for the virtual BTOG annual conference have been published in an e-book supplement of Elsevier’s Lung Cancer Journal. You can view the supplement here.
This fund was for those who have submitted an abstract to the Virtual BTOG 2022 and are a concessionary rate HCP (including allied health professional, nurse specialist, radiographer or trainee doctor up to and including specialist registrar grade). We received … Read More
BTOG is excited to be calling for Trainee Representatives from the Oncology and Respiratory specialities to apply to the BTOG Steering Committee. 2 trainee representatives – 1 from each speciality will be appointed to: Act as a point of contact … Read More
One of BTOG’s key aims is to bring the thoracic oncology community closer together and foster collaboration and education. In our trainee’s survey we heard that you wanted to be connected with other like-minded trainees and therefore we are pleased … Read More
The final NICE guideline on Tobacco: preventing uptake, promoting quitting and treating dependence has been published on the NICE website. You can also find the supporting evidence, tools and resources as well as all the stakeholder comments that were received … Read More
Launched on 30th November 2021, the All-Party Parliamentary Group (APPG) for Respiratory Health has produced a timely report on the impact of COVID on lung cancer. To reflect the views within the lung cancer community, the APPG invited clinicians, professional … Read More
BTOG has launched a series of podcasts called “BTOG does …” where we will discuss a variety of thoracic oncology topics with a different expert each time. The first podcast is BTOG does EGFR mutated lung cancer (available now on the BTOG website). … Read More
You can now read our Annual Report for 2021 which includes a full review of the year ended 31st March 2021 including achievements and performance, activities in our three pillars of Education, Research and Representation, and financial review and statements. Highlights include: BTOG webinars … Read More
Members of the BTOG Committee and the Association of Pulmonary Pathologists have had a consensus statement published in the British Journal of Cancer. The article on Large Cell Neuroendocrine Lung Carcinoma can be read here.
Please see Mesothelioma UK’s evidence submission to the Work and Pension Select Committee’s inquiry into the HSE’s management of asbestos. The committee asked for evidence covering several topics and Mesothelioma UK selected three. You or the organisation you represent may … Read More
Timely and accurate diagnosis is critical for people presenting with symptoms of lung disease. Diagnosing conditions at the earliest opportunity means that people get access to the best available treatments to manage their symptoms, cure or slow the progression of … Read More
The Mesothelioma UK Research Centre – Sheffield is looking for participants in its Research Prioritisation Exercise (RPE) survey. The aim of the mesothelioma RPE is to identify unanswered questions about the mesothelioma patient and carer experience and then to prioritise these … Read More
In response to feedback from trainees and part of BTOG’s work to provide resources for trainees, BTOG is pleased to launch the ‘BTOG Journal Club’. The target audience will be medical trainees of all grades including medical students, junior consultants … Read More
The programme for our 19th annual conference, BTOG 2021, is now available to read and download. Take a look at what you can expect from our first virtual conference.
The National Lung Cancer Audit has published a revised annual report (based on 2018 diagnoses), which includes outlier information for participating trusts. The NLCA website also has individual trust and cancer alliance reports.
It is with great sadness that we let you know that Tom Haswell passed away suddenly at home on Friday 27th November. Tom was a very much loved member of the BTOG Steering Committee and a hugely influential professional lung … Read More
Only a small proportion of lung cancer patients are being offered video consultations says a new report published today1 (26th November 2020), supported by Lung Cancer Nursing UK, the British Thoracic Oncology Group, UK Lung Cancer Coalition and Roy Castle … Read More
In addition to the On Demand feature which allows you to watch webinars you may have missed, we have also made them available to listen to as podcasts. You can access them here and also subscribe to them via the … Read More
The PePS2 Investigators would be most grateful if you would take a minute or two to complete this short survey which will be of significant importance in any decision to try to get access for our PS2 lung cancer patients to … Read More
The updated National Optimal Lung Cancer Pathway has just been released by NHS England. This optimal pathway is primarily designed to improve outcomes in lung cancer by encouraging best practice, reducing variation, and reducing delays in diagnosis, staging and treatment. … Read More
The National Lung Cancer Audit (NLCA) Spotlight Audit on Curative Intent Treatment is published today. This study was aimed at investigating why the curative intent treatment rates in patients with early-stage lung cancer are lower than expected and additionally to … Read More
The Royal College of Radiologists has recently published Radiotherapy for lung cancer – RCR consensus statements. The lung cancer statements should serve as a practical stimulus for lung cancer teams to review their current radiotherapy service to ensure that they … Read More
BTOG would like to say a fond farewell and thank you to Steering Committee members who have recently stepped-down. Matthew Hatton, Sam Janes, Jason Lester, Denis Talbot and Cindy Billingham have worked with BTOG for many years and their contribution … Read More
Dear colleagues, At this difficult time we all want to know how best to treat our patients. For this reason BTOG believes that for COVID-19 infected patients with thoracic malignancies, data capture at the International level is paramount. BTOG therefore … Read More
Colleagues, After careful consideration, BTOG has sadly decided that BTOG 2021 will not go ahead in January 2021. We hope to be able to hold BTOG 2021 in Spring 2021 and our 20th Conference – BTOG 2022 is in the … Read More
The National Institute for Health and Care Excellence’s (NICE) latest impact report on lung cancer is now available on its website. The impact report brings together NICE recommendations and real-world data to highlight how implementing NICE guidance is making a … Read More
Due to succession planning there will be 7 available positions and applications are welcome from the following areas: Medical Oncology Radiology Pharmacy Science/Research Clinical Oncology Surgery Palliative Care Deadline Monday 16 March 2020 BTOG Steering Committee Members will: Sit on … Read More
A new website, launched as part of the My Pleural Effusion Journey project, provides information for patients, carers and clinicians on malignant pleural effusions. My Pleural Effusion Journey was funded by the North West Lung Centre Charity, based at Wythenshawe … Read More
BTOG has now appointed the Steering Committee Trainees: Helen McDill was appointed for Respiratory Trainee Representative and Adam Januszewski was appointed as Oncology Trainee Representative. We received many more applications than we were expecting, and every one was of a … Read More
NICE, the National Institute for Health and Care Excellence, has just published an updated Quality Standard (QS17) for lung cancer in adults. NICE quality standards describe high-priority areas for quality improvement in a defined care or service area. Each standard … Read More
BTOG is excited to be calling for Trainee Representatives from the Oncology and Respiratory specialities to apply to the BTOG Steering Committee. 2 trainee representatives – 1 from each speciality will be appointed to: Act as a point of contact … Read More
Registration is now open for the International Mesothelioma Interest Group meeting, iMig 2020, in Brisbane, Australia, 25th-28th March, 2020. The closing date for abstracts is 30th October and can be submitted online. The event will bring together over 500 delegates from … Read More
The results of EORTC’s survey into the impact of the CONVERT trial have been published in Lung Cancer journal. This will be of particular interest to the BTOG members who took part in the survey.
The Systemic Anti-Cancer Therapy (SACT) team at Public Health England has released the final version of the workbook with the following documents: Companion brief detailing the official trust comments on their data Evaluation report describing the feedback received from trusts … Read More
We are pleased to announce that Tom Newsom-Davis has been appointed Vice Chair of the BTOG Steering Committee. Tom is a consultant in medical oncology at Chelsea and Westminster Hospital, London, where he specialises in thoracic malignancies. He has been … Read More
We send a regular newsletter by email to those of our members who subscribe, click here to see the latest issue. Click here to join and subscribe and get your own BTOG E-News in your inbox.
The BTOG Position Statement 2018 is now available. This document provides the brief background of BTOG and achievements to date and confirms BTOG’s Core Principles and Key Activities. Please view here. British Thoracic Oncology Group Position Statement Final July 2018
The Second Edition of the IASLC Staging Manual in Thoracic Oncology reports on the latest revisions of the tumor, node and metastasis (TNM) classifications of thoracic malignancies, namely, lung cancer, malignant pleural mesothelioma, carcinoma of the esophagus and of the … Read More
BTOG distributed this EORTC survey to our members and the resulting article has just been published: Diversity of brain metastases screening and management in non-small cell lung cancer in Europe: Results of the European Organisation for Research and Treatment of … Read More
Download the BTOG Annual Report (April 2016 to March 2017).
Article from the European Journal of Cancer: Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial Please see article.
ASCO 2017 National Update – Roy Castle Lung Cancer Foundation in partnership with BTOG Friday 9th June 2017 – Wellcome Collection, London The main focus for this Roy Castle Lung Castle Foundation meeting, planned in partnership with the British Thoracic … Read More
Dr Sanjay Popat is Consultant Thoracic Medical Oncologist at the Royal Marsden Hospital and Honorary Clinical Senior Lecturer in the Molecular Genetics and Genomics Group at the National Heart and Lung Institute, Imperial College London. Dr Popat has published in … Read More
